Gatifloxacin

Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial enzymes DNA gyrase and topoisomerase IV. Bristol-Myers Squibb introduced Gatifloxacin in 1999 under the proprietary name Tequin® for the treatment of respiratory tract infections, having licensed the medication from Kyorin Pharmaceutical Company of Japan. Allergan produces an eye-drop formulation called Zymar®. Gatifloxacin is available as tablets and in various aqueous solutions for intravenous therapy.
See more at Wikipedia.org...

Gatifloxacin /gat·i·flox·a·cin/ a fluoroquinolone antibacterial effective against many gram-positive and gram-negative bacteria. [more]Gatifloxacin - Community and Resources